Ignite Creation Date:
2025-12-24 @ 5:21 PM
Ignite Modification Date:
2025-12-29 @ 11:35 PM
Study NCT ID:
NCT05263050
Status:
RECRUITING
Last Update Posted:
2025-12-03
First Post:
2022-02-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
Sponsor:
Fox Chase Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-21
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-02
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-21
First Submit QC Date:
None
Study First Post Date:
2022-03-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-02
Last Update Post Date:
2025-12-03
Last Update Post Date Type:
ESTIMATED